FASN Inhibition Enhances the Efficacy of Chemotherapy in Colorectal Cancer by Inhibiting the DNA Damage Response

Journal:

Cancer Research

Published:

2026-05-15

DOI:

10.1158/0008-5472.can-25-1917

Affiliations:

7

Authors:

15

Go to article

Institutions	Authors	Share
Markey Cancer Center (MCC), United States of America (USA)	7.000000	0.47
University of Kentucky (UK), United States of America (USA)	6.000000	0.40
University of Kansas Medical Center (KUMC), United States of America (USA)	1.000000	0.07
Sagimet Biosciences, United States of America (USA)	1.000000	0.07

Interested in Medical Biochemistry and Metabolomics?